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Abstract
Objective: To characterize cortico-diaphragmatic pathway involvement in multiple sclerosis (MS) by means of transcranial magnetic
stimulation (TMS), and verify its clinical impact.
Methods: TMS from diaphragm (Dia), and abductor digiti minimi (AbdV8) was performed in 26 MS patients. Phrenic nerve (PN)
conduction study was also performed. Expanded disability status scale (EDSS) and fatigue descriptive scale (FDS) were measured. Forced
vital capacity (FVC), forced expiratory volume at the first second (FEV1), peak expiratory flow (PEF) were tested: the predicted percentage
value (% pred) was considered.
Results: Cortical motor evoked potential (Cx-MEP) latency and central motor conduction time (CMCT) were prolonged, respectively, in
31 and 23% of patients from Dia, in 76 and 79% from AbdV8. PN-compound motor action potential (CMAP) was normal. EDSS correlated to
Cx-MEP from AbdV8 (P , 0:01), and PN-CMAP amplitude (P , 0:05), FEV1 % pred (P , 0:01), PEF % pred (P , 0:01). PN-CMAP
amplitude correlated to FVC % pred P ¼ 0:05, FEV1 % pred P , 0:01, PEF % pred P , 0:01. Fatigue was related to AbdV8 Cx-MEP and
CMCT (P , 0:05 and P , 0:01).
Conclusions: Cortico-diaphragmatic pathway is impaired only in a minority of MS patients. Lack of correlation between TMS findings
from Dia and respiratory tests argues against its routinary use to detect subclinical respiratory alterations. Fatigue seems to be related to the
motor impairment rather than to respiratory distress. q 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Respiratory muscle weakness in multiple sclerosis (MS)
is usually described in the advanced phase of the disease,
and accounts for the majority of the fatal events in such
patients (Mc Alpine and Compston, 1952). However, in
some cases respiratory involvement may occur earlier in
the course of the disease, particularly during relapses
(Guthrie et al., 1952). Respiratory muscle weakness could
also contribute to fatigue and increased sense of effort
experienced by MS patients.
MS has been the first neurological condition to be studied
by both electrical (Cowan et al., 1984) and magnetic (Hess
et al., 1986) stimulation of the brain.
Several studies have reported prolonged central motor
conduction time (CMCT) to different muscle groups in
patients with definite MS (Cowan et al., 1984; Mills and
Murray, 1985; Ingram et al., 1988). Recently this technique
has been successfully proposed for the non-invasive study of
the diaphragm (Dia) (Zifko et al., 1996, Similowski et al.,
1996) and phrenic roots (Chokroverty et al., 1995; Simi-
lowski et al., 1997). There are only few studies which
addressed the diaphragmatic impairment in MS by means
of transcranial magnetic stimulation (TMS) (Garland et al.,
1996; Lagueny et al., 1998).
Garland et al. (1996) found Dia alterations in CMCT in
70% of their cohort, while Lagueny et al. (1998) demon-
strated altered MEP latencies from Dia in 41% of the
patients studied. The latter claimed also the usefulness of
TMS for revealing infraclinical demyelinating lesions on
central motor pathways down to the Dia.
However, the evidence of a poor correlation between
central motor conduction abnormalities and clinical signs
(Hess et al., 1987) questions a reliable prognostic value of
this technique to detect respiratory subclinical involvement.
Thus we aimed to characterize the TMS findings,
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concerning the Dia muscle, in MS patients without severe
impairment of respiratory function, and to verify the clinical
impact of a likely subclinical cortico-diaphragmatic impair-
ment, namely on fatigue.
2. Methods
Twenty-six patients (16 females and 10 males), mean age
44.1 ^ 9.8 years (range 26–61), were recruited. The patients
were selected on the basis of a good compliance and toler-
ability to the respiratory or neurophysiological tests. None
of them showed dyspnea. The inclusion criterion was a
diagnosis of definite or probable MS, according to Poser’s
criteria (Poser et al., 1983), and the exclusion criteria were
the absence of history for epilepsy, cranial surgery or pace-
maker use. Moreover none of the patients showed signs of
peripheral neuropathy. Nine of them presented as primary
progressive (PP), 12 as secondary progressive (SP) and 5 as
relapsing remitting (RR) clinical form of the disease; all
patients had been in stable clinical conditions for at least
2 months prior to the study. The severity of the disease was
measured by the expanded disability status scale (EDSS)
(Kurtzke, 1983).
Subjective fatigue was evaluated using the fatigue
descriptive scale (FDS) (Iriarte and De Castro, 1994).
Fifteen normal control subjects (9 females and 6 males),
aged between 26 and 58 years (mean 38.2 years old) were
examined as controls. All patients and volunteers gave their
informed consent to the investigation, which was approved
by the local ethical committee. All subjects were studied
sitting in a chair equipped with head rest and with their
abdomen unbound.
2.1. Neurophysiological tests
The recordings were carried out from hemidiaphragm
(Dia), and from abductor digiti minimi (AbdV8) for compar-
ison. The recording electrodes were placed over the muscle
belly. For the Dia, the surface recording electrodes were
applied 5 cm superior to the tip of the xyphoid process
(G1) and on the costal margin 16 cm from the G1 electrode
ipsilaterally (G2) (Zifko et al., 1996); the ground electrode
was positioned on the ipsilateral upper arm (G3) (Fig. 1).
Magnetic stimulation of the motor cortex was carried out
by a MAGSTIM 200 stimulator, producing a maximal
magnetic field of 2.0 Tesla. A standard stimulation proce-
dure was performed using a round coil of 9 cm diameter.
The coil was applied to the scalp region, overlying the
vertex in the mid-sagittal line, to evoke a cortical motor
response (Cx-MEP) from Dia to C3–C4, according to the
International 10–20 system, and to evoke a Cx-MEP from
Abd V8. For the root stimulation (spinal motor evoked
potentials–Sp-MEP), the round coil was kept flat against
the upper cervical vertebral column with the handle pointing
towards the feet, and the head of the patients was slightly
bent forward. The largest amplitude was obtained generally
1–2 cm above the C5 spine.
The stimulus intensity was adjusted to obtain the largest
reproducible responses (range 65–100% stimulator output).
The magnetic pulse was monophasic; thus the coil’s orien-
tation was selected according to the cortical site under
examination (Claus et al., 1990). During TMS, the patient
was required to perform a slight contraction according to the
muscle group under study; the level of contraction was
defined for each subject, in order to obtain the largest ampli-
tude of the evoked responses among 5 waves recorded for
each muscle site. For the Dia, the patient had to perform a
quiet inspiratory effort; recordings were rejected if electro-
cardiogram artifacts were encountered and the stimuli were
repeated.
For all the patients, the neurophysiological recording was
carried out bilaterally. The CMCT was calculated by
subtracting latencies of the spinal evoked potentials from
those obtained after cortical stimulation (CMCT¼ (Cx-
MEP2 Sp-MEP) latency).
Three conventional parameters of abnormality in
response to TMS were considered: (1) prolongation of the
Cx-MEP latency; (2) prolongation of CMCT, and (3)
absence of Cx-MEP. Cx-MEP latency was measured at
the onset of the first negative deflection of the evoked
response. Cx-MEP amplitude was not considered because
of the large variability even in normal conditions (Amassian
et al., 1989; Eisen, 1992).
In all subjects, phrenic nerve (PN) conduction studies
were performed bilaterally with percutaneous electrical
stimulation at the border of the sternocleidomastoideus
muscle. The stimulus duration ranged from 200 to 500 ms.
2.2. Respiratory tests
The respiratory function was studied by means of the
routinary respiratory tests to evaluate the maximal voluntary
effort: values of forced vital capacity (FVC), forced expira-
tory volume at the first second (FEV1) and peak expiratory
flow (PEF) expressed as percentage of the predicted values.
Maximal flow–volume curve was recorded using a spirom-
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Fig. 1. Positioning of surface electrodes for recording from Dia. G1 indi-
cates the active electrode, 5 cm from the tip of the xyphoid (Xy); G2
indicates the reference electrode, 16 cm from G1 on the costal margin
(CM), G3 indicates the ground electrode.
eter (Sensormedics). Values exceeding 80% of predicted
values were considered as normal (FVC % pred; FEV1 %
pred, PEF % pred). Nocturnal mean PO2 saturation was
measured and 80% was considered the lower limit; the mini-
mum PO2 value was also included as well as the number of
desaturation events longer than 10 s in 1 h (Des Index).
2.3. Statistics
Results were expressed as mean ^ SD. Differences
between MS patients and controls were calculated by
means of unpaired Student’s t test. Correlations between
respiratory and neurophysiological finding were measured
by means of parametric (simple regression line). Non-para-
metric statistical analysis (Spearman rank correlation coef-
ficient) was applied to correlate clinical score to respiratory
and neurophysiological measures. Probability values less
than 0.05 were considered significant. The statistical soft-
ware Statview SaS was used.
3. Results
Patients’ duration of the disease was 12.8 ^ 6.5 years and
clinical conditions ranged from minimal to severe disability
(EDSS score 5.5 ^ 2.1, range 1.5–8.5). Mean FDS score
was 6.5 ^ 3.1 (range 3–14).
3.1. Neurophysiological tests
The results obtained from TMS were compared with the
normal values of the age-matched controls. The upper limits
of MEP latency and CMCT were set at the mean value
obtained in the controls ^ 2.5 SD.
TMS findings from Dia and Abd V8 are reported in Table
1. The Cx-MEP and CMCT from Dia were slightly signifi-
cantly longer in MS patients, with respect to controls
(respectively, P ¼ 0:025 and P ¼ 0:039). The Cx-MEP
latency and CMCT from AbdV8 were significantly longer
with respect to controls (respectively, P , 0:0001 and
P ¼ 0:0004). No significant differences were found in Sp-
MEP latency between controls and MS patients in either
recording from Dia or from AbdV8. In the recording from
Dia, about 31% of MS patients showed alterations in Cx-
MEP latency and 23% in CMCT on at least one side, while
in the recording from AbdV8 76% of the patients showed
alterations in Cx-MEP latency and 79% in CMCT on at least
one side. Conversely, none of the patients from AbdV8 and
only two patients from Dia (7%) showed prolonged Sp-MEP
latency recording. Dia and AbdV8 Cx-MEP was could not
be obtained in only one patient (patient nr. 20).
The percentage of abnormal Cx-MEP latency and CMCT,
when both sides were combined, was even lower for the
hemidiaphragms (19% of prolonged Cx-MEP latency and
18% for slowed CMCT), in respect to the upper limbs (64
and 54%, respectively).
Fig. 2 shows 3 patterns of Cx-MEP and Sp-MEP from
ABD V8 and DIA recorded in MS patients.
The values of latency and amplitude of PN-CMAP are
reported in Table 2. On the basis of the mean ^ 2.5 SD of
the CMAP latency values of the controls, latencies over
9 ms were considered pathological. Only one patient (no.
2) showed prolonged CMAP latency value on one side
(10.2 ms). The mean value of both CMAP latency and
amplitude did not differ between MS patients and controls.
The comparison among the 3 clinical forms of MS
showed significant differences only in Cx-MEP latency
and CCT from Abd V8 between PP (respectively,
27.1 ^ 2.3 and 14.0 ^ 3,2) and RR (respectively,
20.3 ^ 3.4 and 7.1 ^ 2.1) (P , 0:01**) and in CCT from
Abd V8 between RR and SP (12.5 ^ 5.2) (P , 0:05*). This
is likely due to the more severe clinical conditions of the PP
and SP patients in our sample (mean EDSS-PP: 5.7; mean
EDSS-SP: 5.9; mean EDSS-RR: 3.7).
3.2. Respiratory tests
All patients were able to perform the spirometric and
oximetric tests. Four patients (15%) showed values of
FEV1 % pred and PEF % pred under 80%; one patient
(4%) showed reduced values only of FEV1 % pred and 6
patients (23%) only of PEF % pred.
The minimum values of nocturnal PO2 saturation
decreased below 80% in 6 patients (23%); conversely the
mean O2 saturation value and Des Index were still in the
normal range. The findings are reported in Table 3.
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Table 1
TMS findings from Diaphragm and Abductor Digiti Minimi musclesa
Cx-MEP (ms) P Sp-MEP (ms) P CMCT (ms) P
Diaphragm
Controls 13.6 ^ 1.4 (11.3–16) 7.6 ^ 0.7 (6.7–9) 6.0 ^ 1.3 (4.4–8.5)
MS patients 15.4 ^ 2.6 (11.7–24.7) 0.025 8 ^ 1.4 (5.0–11.5) 0.75 7.0 ^ 2.0 (4.4–13.2) 0.039
Abductor Digiti Minimi
Controls 19.6 ^ 1.4 (17.2–22.2) 12.7 ^ 1.0 (11.3–16.3) 6.7 ^ 2.1 (5–8.9)
MS patients 25.3 ^ 5.6 (16–40) , 0.0001 13.1 ^ 1.5 (10.0–15.7) 0.49 12.2 ^ 5.3 (4.7–26.8) 0.0004
a TMS, transcranial magnetic stimulation; MS, multiple sclerosis; Cx-MEP, cortical motor evoked potential; Sp-MEP, spinal motor evoked potential;
CMCT, central motor conduction time.
3.3. Correlations
Disease duration was not correlated to neurophysiologi-
cal parameters. Disease duration was correlated to FEV1%
(r ¼ 0:56, P ¼ 0:0001), but not to other respiratory para-
meters.
EDSS correlated to the Cx-MEP latency from AbdV8
(r ¼ 0:39, P ¼ 0:008) (Fig. 3). EDSS was also correlated
to FVC % pred (r ¼ 20:60, P , :0001), FEV 1 % pred
(r ¼ 20:55, P ¼ 0:0002) and PEF % pred (r ¼ 20:49,
P ¼ 0:001).
Among the neurophysiological parameters, TMS findings
did not show any significant correlations with the respira-
tory tests; only PN-CMAP amplitude significantly corre-
lated to FEV 1 % pred (r ¼ 0:40, P ¼ 0:008) and to PEF
% pred (r ¼ 0:42, P ¼ 0:005).
FDS was correlated to EDSS (r ¼ 0:44, P ¼ 0:004) and
the duration of the disease (r ¼ 0:4; P ¼ 0:01). FDS score
significantly correlated only to Cx-MEP latency and CMCT
from AbdV8 (respectively, r ¼ 0:52, P ¼ 0:005; r ¼ 0:52,
P ¼ 0:004). FDS score did not correlate either to TMS find-
ings from Dia or to respiratory tests.
3.4. Differences between groups
If we subdivide the MS patients into those presenting
mild subclinical respiratory dysfunction and those who do
not, the former have the most long-lasting duration of the
disease (P , 0:0001), and a more severe clinical pattern,
expressed by a higher EDSS score (P , 0:0001).
The neurophysiological parameters obtained by TMS and
electrical stimulation of the PN did not differ in the two
groups. Conversely the group with mild respiratory
dysfunction showed significantly lower values of FVC %
pred, FEV1 % pred, PEF % pred (P , 0:0001).
A chi-square test, performed to evaluate the validity of
TMS, both from Dia and AbdV8, to discriminate patients
with or without respiratory distress, did not show significant
result (chi-square 0.19, P-value 0.89; chi-square 0.68, P-
value 0.40, respectively). In fact, in 8 patients showing
altered respiratory parameters, TMS from Dia was normal;
TMS from AbdV8 was normal only in two patients (8%).
Conversely, only in 4 patients, TMS from Dia revealed
subclinical alterations of diaphragmatic cortical drive, but
in 9 patients (36%) TMS from AbdV8 showed pyramidal
alterations.
4. Conclusions
Respiratory alterations may occur in advanced MS, but it
may also complicate relapses earlier in the disease. In para-
paretic MS patients, expiratory muscle weakness increases
as the upper extremities become involved; the presence of
concomitant bulbar dysfunction enhances the likelihood of
aspiration pneumonia (Smeltzer et al., 1988). However, the
incidence of respiratory muscle involvement in MS is prob-
ably underestimated because patients with restricted motor
activity usually do not complain of dyspnea. On the other
hand, even in the milder form of the disease, impaired motor
conduction in the respiratory pathway may contribute to
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Table 2
Nerve conduction study from the phrenic nervea
PN-CMAP latency (ms) P PN-CMAP amplitude (mV) P
Controls 7.2 ^ 0.8 (6.3–9) 0.9 ^ 0.4 (0.4–1.6)
MS patients 7.2 ^ 1 (5.4–10.2) 0.8 0.7 ^ 0.4 (0.3–1.9) 0.1
a PN-CMAP, compound motor action potential of the Phrenic nerve; MS, multiple sclerosis.
Fig. 2. Three patterns of Cx-MEP and Sp-MEP from Abd V8 and Dia. Pattern A: prolonged Cx-MEP and normal Sp-MEP either from Abd V8 or Dia; pattern B:
prolonged Cx-MEP and normal Sp-MEP from Abd V8, normal Cx-MEP and Sp-MEP from Dia; pattern C: normal Cx-MEP and Sp-MEP either from Abd V8 or
Dia.
fatigue and to the increased sense of effort experienced by
MS patients (Foglio et al., 1994; Olgiati et al., 1988, 1989).
The activity of Dia is controlled by non-volitional
mechanisms originating in the brainstem nuclei, which
also regulate respiratory homeostasis (Khedr and Trakhan,
2001; Similowski et al., 1996). The voluntary respiratory
pathway operates during wakefulness, allows behavioural
modulation of respiration and the performance of volitional
respiratory movement (Plum, 1970; Newson-Davis, 1974).
The system depends on willed activity from the cerebral
cortex through the corticospinal tracts and descending in
the dorsolateral columns of the spinal cord (Plum, 1970;
Aminoff and Sears, 1971; Howard et al., 1992).
In humans, the neurophysiological basis of the voluntary
control of breathing appears to reside in the motor cortex
(Foerster, 1936; Maskill et al., 1991), more precisely ante-
rior to the thoracic muscle site of representation. Previous
studies seem to confirm that cortical representation of each
hemidiaphragm is predominantly contralateral (Maskill et
al., 1991, Similowski et al., 1996), although some other
findings are suggestive of a bilateral cortical representation
(Khedr and Trakhan , 2001).
The study by Corfield et al. (1998) demonstrated that
motor cortical excitation of the diaphragm is not mediated
via brainstem respiratory neurons but, most likely, via the
more direct corticospinal tract, fast conducting and oligosy-
naptic (Gandevia and Rothwell, 1987).
TMS represents a valid tool for a non-invasive investiga-
tion of the cortico-diaphragmatic pathway and is a high reli-
able measure in the diagnosis of MS (Ravnborg et al., 1992;
Di Lazzaro et al., 1999). TMS seems to be useful also for
revealing infraclinical demyelinating lesions on the central
motor pathways down to the Dia (Lagueny et al., 1998).
About 30 % out of our MS patients showed CMCT altera-
tions from Dia. However, the mean value of Cx-MEP
latency of our patients was slightly longer with respect to
controls. Our Cx-MEP latency values from Dia are compar-
able with those reported by Gandevia and Rothwell (1987)
and Zifko et al. (1996), although 1.5 ms longer than those
reported by Khedr and Trakhan (2001). Such a discrepancy
can be due to methodological differences with regard to the
site of cortical stimulation and of the recording electrodes.
In the study by Lagueny et al. (1998), the percentage of
abnormal MEP latency and CMCT was higher for the hemi-
diaphragms than for the upper limbs and was roughly the
same for the hemidiaphragms and the lower limbs. Conver-
sely, in our study we found a higher percentage (76%) of
MS patients with CMCT alterations recording from AbdV8
as compared to the percentage of patients with Dia TMS
alterations. Furthermore the Cx-MEP latency recorded from
AbdV8 was significantly longer than that recorded from Dia
when compared to controls. These findings support the
evidence that in normal subjects the CMCT of different
muscles is compatible with the craniocaudal distribution
of the motor nuclei and therefore with the conduction
distance along the corticospinal pathway. Our observations
are also in agreement with previous studies (Buyse et al.,
1997; Smeltzer et al., 1988) on the respiratory involvement
in MS, which found that the involvement of expiratory
muscles appeared to be more pronounced than that of the
inspiratory muscles. The authors explained that paralysis in
advanced MS tended to ascend slowly from lower extremi-
ties to upper extremities, as a result, the first respiratory
muscles to be affected should be the abdominal muscles
followed by the intercostal muscles. Dia, innervated by
the phrenic nerve, may be expected to be the last to be
affected.
In our study, none of the MS patients showed prolonged
Sp-MEP latency, varying from other reports (Lagueny et al.,
1998). Furthermore, in only one MS patient PN-CMAP
latency was prolonged. Such findings do not allow the
confirmation of a peripheral involvement in MS (Waxmann,
1993).
Disease duration was not correlated to neurophysiologi-
cal parameters, and, among the respiratory parameters, only
to FEV1 % pred (P ¼ 0:0001). We found a correlation
between neurological disability and pulmonary dysfunction,
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Fig. 3. Correlation between EDSS and Cx-MEP latency from Abd V8.
Table 3
Respiratory tests of the MS patientsa
FVC % pred FEV1% pred PEF % pred Mean SatO2 Min SatO2 Des index
83 ^ 15 (54–107) 96 ^ 17.5 (59–120) 79 ^ 22 (27–124) 93.2 ^ 2.6 (85.6–98) 79 ^ 11.8 (36–89) 5.2 ^ 4.7 (0.7–16.3)
a FVC % pred: percentage of the predicted values of forced vital capacity; FEV 1 % pred: percentage of the predicted values of forced expiratory volume at
the first second; PEF % pred: percentage of the predicted values of peak expiratory flow; Mean Sat O2: mean oxygen saturation; Min Sat O2: minimum oxygen
saturation; Des Index: desaturation index.
in fact in the neurologically more disabled group, signifi-
cantly worse pulmonary function tests (FVC % pred, FEV1
% pred, PEF % pred) were measured, as described by others
(Smeltzer et al., 1988). This is probably due to the difficulty
of some of these patients with a more severe motor impair-
ment, to control the inspiratory and expiratory muscles
when utilized during maximal effort. In fact, performing a
pulmonary function test can be quite stressful for MS
patients who often show poor tolerance and complain of
fatigue (Olgiati et al., 1988).
EDSS was correlated to TMS findings from AbdV8,
generally involved in the pyramidal impairment. Conver-
sely, EDSS, expressing the degree of neurological disabil-
ity, was not correlated to TMS findings from Dia; this can be
due to the lack of items specific to test the respiratory func-
tion within such a score. All the more reason that we did not
find any correlations among TMS findings from Dia and the
respiratory tests. However, it should be considered that the
use of other techniques, such as the transdiaphragmatic
twich tensions, could improve these correlations.
We used FDS score to evaluate the severity and quality of
fatigue. It isapparent that theFDSprovidesaglobalevaluation
of the sensation of fatigue. We found that FDS score was
directly related to EDSS and duration of the disease, as
expected, this could mean that greater fatigue developed in
weaker subjects and with longer history of disease. FDS was
also directly related to TMS findings from AbdV8; previous
reports found that the degree of symptomatic fatigue was
proportional to thatofpyramidal tract involvement(DeCastro
et al., 1994), but this was not confirmed by others (Sheean et
al., 1997). Conversely, the score of fatigue did not signifi-
cantly correlate to TMS findings from Dia and any of the
respiratory parameters. The lack of a direct relationship
between peripheral and central motor conduction abnormal-
ities to the Dia and fatigue seems to question the possible role
of the cortico-diaphragmatic pathway involvement as contri-
buting factor for the respiratory muscle weakness and conse-
quently to a symptomatic fatigue in these patients.
In conclusion, TMS from Dia shows subclinical cortico-
diaphragmatic impairment in a minority of MS patients
without pulmonary symptoms and with still fairly normal
spirometric values. Nevertheless, the lack of correlation
between TMS findings from Dia and respiratory tests argues
against the routinary use of TMS from Dia, to detect subcli-
nical respiratory alterations. Moreover, fatigue seems to be
related to the motor impairment rather than to respiratory
distress. However, subclinical TMS alteration from Dia
could represent a predictor of the respiratory evolution in
MS patients but to confirm such an issue, a longitudinal
follow-up study is needed.
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